Asian Journal Of Social Pharmacy

Abstract: Objective To study the current status of independent clinical laboratory (ICL) in China to offer some suggestions for further development of the industry because independent clinical testing is gradually occupying an important position in the medical market with the change of medical service mode. Methods The PEST-SWOT matrix model was constructed to sort out the strength and weakness, opportunities and threats of ICL and medical institutions. Results and Conclusion ICLs should enhance their social recognition by improving testing technology and industry operating standards. At the same time, it is also necessary to enhance their position in the clinical diagnosis industry and promote diversified competition in the field of clinical diagnosis so as to better help the development of national grading diagnosis and precision medicine. From the perspectives of SO, ST, WO, and WT, the development strategies of ICL are proposed, including personalized clinical diagnosis services and the construction of a database, and the family doctor system with community + ICL services. The remote diagnostic services should be implemented to help national graded diagnosis and treatment, and different operation schemes should be made to conform to market development. Besides, the access standards for ICL must be strictly required. Then, differentiated operations of enterprises should be valued for establishing industry brands and social awareness. Lastly, enterprises must focus on talents construction and management.

Key words: independent clinical laboratory, clinical diagnosis market, clinical diagnosis institutions, PESTSWOT matrix